Related Experiment Videos
Effectiveness and safety of alternate-day simvastatin and fenofibrate on mixed hyperlipidemia
M Kayikçioğlu1, F Ozerkan, I Soydan
1Department of Cardiology, Ege University Medical School, Izmir, Turkey. omkay@superonline.com
The American Journal of Cardiology
|April 6, 1999
Abstract:
This randomized prospective clinical study evaluated the lipid-lowering effects and safety of a new combination regimen in patients with mixed hyperlipidemia. The data show that alternate-day simvastatin and fenofibrate therapy was as effective as the standard daily combination of the same drugs at the same doses, and it was safer, less expensive, and more tolerable.